ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Tattooing in adolescents and young adults

Tattooing in adolescents and young adults
Literature review current through: Jan 2024.
This topic last updated: Nov 09, 2023.

INTRODUCTION — The epidemiology and health hazards associated with tattooing will be reviewed here. Body piercing and issues related to tattooing in pregnancy are discussed separately. (See "Body piercing in adolescents and young adults" and "Maternal adaptations to pregnancy: Skin and related structures", section on 'Tattoos and piercing'.)

For the purposes of this topic, "tattooing" generally refers to permanent tattoos. However, some sections discuss temporary (eg, henna) tattoos.

EPIDEMIOLOGY — Tattooing is increasingly common among adolescents and young adults [1-6].

Although there are few data regarding the prevalence of tattooing in adolescents, small surveys of college students (18 to 25 years of age) in the United States consistently indicate that 20 to 25 percent have tattoos [1,5,7]. The prevalence is slightly higher in larger surveys of adults (18 to 35 years of age) in the United States, ranging from 22 to 47 percent, depending upon the age groupings [6,8,9].

Surveys evaluating the association between tattooing and high-risk behaviors (eg, tobacco use, drug use, sexual activity) in adolescents and young adults have inconsistent results [3,10-19].

Little information is available about tattoo removal in adolescents and young adults. In one survey of college students, 6 of 149 tattoos (4 percent) had been removed [1]. In a 2015 survey of 2225 adults, 23 percent of those with tattoos reported having had regrets [6]. Common reasons for regret included being too young when they got it, the tattoo no longer reflects their lifestyle, the tattoo was poorly done, and the tattoo is not meaningful. (See 'Tattoo removal' below.)

COUNSELING PATIENTS ABOUT TATTOOS — Clinicians and school nurses may be the first and perhaps the only source of credible information about tattooing for children and adolescents [20]. Adolescent and young adult patients are more likely to discuss body art if the clinician is not judgmental. If patients perceive negative judgment from the clinician, they may seek information from other sources (eg, friends, commercial tattoo artists) [20].

Regulations about the age of consent for tattooing differ from state to state [21]. (See 'The tattooing process' below.)

Proactive counseling – Proactive counseling can begin as early as first grade [20,22]. Such counseling does not address tattoos directly but highlights internal empowerment and self-esteem, which can bolster self-worth, decision making, and confidence, which in turn may foster healthy decision-making skills about tattoos and other decisions with long-term consequences. Similarly, for older children and adolescents, proactive counseling focuses on positive physical and psychosocial development rather than pros and cons of tattoos.

Patients contemplating tattoos – When counseling patients who are thinking about tattooing but have not yet made up their mind, clinicians can [23-25]:

Encourage them to talk with others who have been tattooed and/or had tattoos removed.

Remind them that tattoos are permanent; suggest that they obtain a henna tattoo to see what it is like to have a tattoo.

Urge them not to make the decision under pressure, in haste, or while intoxicated.

Provide education and resources (table 1) to help them make informed decision.

Educate them about the difficulty, expense, and potential incompleteness of tattoo removal. (See 'Tattoo removal' below.)

Discuss the motivational factors (ie, perceived benefits), costs, and potential risks; potential motivations for obtaining tattoos in adolescents and young adults include [6,7,14,15,20,26]:

-To redefine themselves

-To take control of their bodies and identities

-To be like their friends

-To feel unique

-Permanent makeup (eg, eye liner, eyebrow, coverage for scars, etc)

Costs and potential risks of tattooing include [6,27]:

-The cost of the tattoo placement

-Negative response from others (eg, caregivers, teachers, employers)

-Pain (no topical anesthetic is used for tattoo placement)

-Infectious and noninfectious complications, including the potential for prolonged bleeding in patients with bleeding disorders or receiving anticoagulant therapy (see 'Health risks' below and 'Other considerations' below)

-The meaningfulness of the tattoo may change over time; they may regret obtaining the tattoo later in life

-Complete removal may not be possible if they subsequently decide to have the tattoo removed

-The cost and pain of tattoo removal if they subsequently decide to have the tattoo removed (see 'Tattoo removal' below)

Relative contraindications to obtaining a tattoo – Relative contraindications to obtaining a tattoo include [28]:

Oral isotretinoin therapy for acne (may impair healing time) [29]

History of keloid formation (keloids could develop within the tattoo) [30]

Moles or melanocytic nevi (the tattoo could make it difficult to monitor for changes suggestive of melanoma); tattoos should not be placed on scars from melanoma resection or lymph node dissection

Skin conditions associated with the Koebner phenomenon (development of skin lesions at sites of skin trauma); these conditions include psoriasis, lichen planus, vitiligo, and discoid lupus

Immune compromise, whether due to infection, medication, or other conditions [31]

In addition, we consider having a bleeding disorder or receiving anticoagulation therapy to be a relative contraindication to obtaining a tattoo. Consultation with the patient's hematologist or specialist managing anticoagulation therapy is recommended before obtaining a tattoo.

Patients who have decided to get a tattoo – If the patient decides to proceed with tattooing, the clinician can help them make informed decisions about [25]:

The site and design of the tattoo – The site may affect the ability to control who is able to see the tattoo [27]. The design may affect the likelihood of negative response.

The tattoo artist and studio – Patients may be better able to choose a tattoo artist/studio if they visit several studios to observe placement of a tattoo before making a decision. This allows the patient to see if the artist is certified by the Alliance of Professional Tattooists, uses sterile technique (eg, uses disposable gloves and disposable or adequately sterilized needles, cleans the site with an antimicrobial solution), and provides appropriate aftercare instructions. (See 'Prevention of infection' below and 'Studio tattoos' below.)

Individuals who are considering a noncertified setting for their tattoo should inquire about the equipment and pigment that are being used. Amateur artists are more likely to use discarded or defective equipment.

The clinician can also provide anticipatory guidance about complications and indications for medical care. (See 'Health risks' below.)

THE TATTOOING PROCESS

Studio tattoos

Tattoo studios and artists – Most tattooing is performed in commercial studios, although studio artists may establish temporary locations (eg, flea markets, concerts).

Regulations for tattoo artists and studios vary geographically [25]. Clinicians should become familiar with the regulations in their cities, counties, and states. In the United States, a compendium of state laws, statutes, and regulations is available from the National Conference of State Legislatures.

Tattoo artists routinely learn their trade either by self-teaching or by observing others; few complete apprenticeships. A standardized procedural curriculum is lacking. Tattoo artists are not required to complete any formal training, even in states that require examinations [32]. The Alliance of Professional Tattooists (APT) is a nonprofit educational organization that promotes safety and provides information to tattoo artists, clients, and legislators. Artists must have a minimum of three years' experience with appropriate references to become APT certified [33].

Few states require examinations and continuing education about anatomy, universal precautions, disease transmission, skin diseases, sterilization procedures, sanitation, personal hygiene, or aftercare instructions [21,32].

A 2011 review of state tattooing regulations in the United States found that sanitation was effectively regulated in 36 states, infection control in 26, and training in 15 [21]. However, only 14 states effectively regulated all three.

Tattoo design – The client chooses a design from illustrations on display at the studio or provides the artist with an illustration.

Procedure – The skin should be cleaned with an alcohol and iodine solution. The tattoo design is then drawn on the skin by hand or with a stenciling machine. Ink is applied to the design with needles that have been dipped in ink that has been poured into disposable ink cups.

Most commercial tattoo artists apply the ink using a handheld, electric-powered machine (picture 1). This device is held several centimeters away from the skin and has a needle bar that moves up and down between 50 to 3000 times per minute [34]. Several needles may be attached to the end of the needle bar and are responsible for inserting the pigment into the skin. The number of needles produces the desired effect: A single needle creates a fine line; increasing numbers of needles create thicker lines, shading, or solid color.

The skin is repeatedly punctured using solid bore needles to allow the tattoo pigment to leach into the dermis, where it is taken up by macrophages [35,36]. The depth of the puncture varies from 1 to 4 mm [34]. During the tattooing process, blood and serosanguineous fluid seep onto the skin and are wiped away by the artist [35].

Tattoo ink/coloring agents – The coloring agents of tattoo ink include inorganic metallic salts, different types of organic molecules, and organic dyes [37,38]. Auxiliary ingredients may be added to make the ink more suitable for tattooing [39]. The composition of inks has changed over time; aluminum, oxygen, titanium, and carbon are more common than metallic salts such as mercury, cadmium, and cobalt, but metallic salts continue to be used [38,40,41]. Allergenic metals (eg, chromium, nickel, and cobalt) may exceed safe allergologic limits [41]. Most of the commercially available tattoo compounds are azo pigments or polycyclic compounds, some of which are carcinogenic. (See 'Cancer' below.)

Tattoo pigments are not routinely reviewed or regulated by the US Food and Drug Administration (FDA) for intradermal use and contain nonstandardized ingredients [38]. In one study, samples of 30 tattoo inks were chemically analyzed and results compared with the information supplied by the manufacturer [42]. Among the 30 pigment samples, the most commonly identified elements were aluminum (87 percent), oxygen (73 percent), titanium (67 percent), and carbon (67 percent). The elemental analysis was usually consistent with the information supplied by the manufacturer, but there were important exceptions. Further research indicates that some pigments are industrial-grade colors suitable for printers' ink or automobile paint [43,44]. Most tattoo pigment manufacturers do not provide a description of the ingredients used in tattoo pigments, but one state (California) requires that tattoo pigments provide an itemization of ingredients [32].

The FDA considers tattoo inks to be cosmetics and the pigments used in the inks to be color additives [45,46]. As color additives, the pigments used in the inks are subject to premarket approval under the Federal Food, Drug, and Cosmetic Act, but the FDA generally has not exercised its authority over tattoo pigments [45]. Outbreaks of skin infection related to pigment contamination have occurred [47-49]. (See 'Localized infection' below.)

Amateur tattoos — Amateur tattoos may be applied or placed by friends or acquaintances, often in an unsanitary setting. These tattoos often are placed using primitive instruments, such as pencils, pens, or other sharp objects. The pigments could be unconventional and may incorporate available materials, such as charcoal, ink, mascara, or discarded pigment and equipment from professional studios. Adolescents may obtain amateur tattoos because they cannot find a studio that will tattoo minors or because they cannot afford to pay for a studio tattoo [34].

Henna tattoos — Henna-based body art is performed by temporarily applying pigment to the surface of the skin. Henna tattoos last between days to one month, depending upon the time of henna exposure. The pigment is derived from dried powder of the plant Lawsonia inermis, which in its native form appears red and is commonly used for dying hair and skin in many cultures. Henna is usually applied as a paste via syringe or stylus, left on the skin or hair for 6 to 12 hours, and then washed off. Red henna is often mixed with black henna (paraphenylenediamine [PPD]) or other plant-based pigments to enhance the staining contrast [50]. The combination of red henna and PPD generally is referred to as "black henna," but also may be called "blue henna," "skin painting," or "pseudo-tattooing."

AFTERCARE INSTRUCTIONS — After the tattoo is applied, petroleum jelly or a similar ointment is applied to the skin to prevent oozing of serosanguineous fluid. The artist bandages the tattoo and should provide aftercare instructions, including recommending that the client cleanse the site twice daily with an antimicrobial soap and avoid contact with the site except for cleaning [34-36].

Tattoos take approximately two weeks to heal [25]. During this time, the risk of infection is increased. We advise patients to avoid swimming, soaking in water, and directing shower jets onto the site of the tattoo. We also advise them to avoid sun exposure, to use sunscreen if sun exposure cannot be avoided, and to wear loose clothing that will not stick to the tattoo site [51].

HEALTH RISKS — Little information is available about the incidence of complications of tattooing because they are infrequently reported to state health departments or in the medical literature [52]. Localized infections and skin reactions appear to be the most frequent complications; in addition, the release of serosanguineous fluid and blood during/after the tattooing procedure may result in blood-borne diseases [53].

Localized infection — Tattooing may be associated with localized skin infection due to Staphylococcus aureus (picture 2), Streptococcus pyogenes, and other bacterial organisms, including nontuberculous mycobacteria (eg, Mycobacterium chelonae, Mycobacterium haemophilum (picture 3), Mycobacterium abscessus) [36,47-49,53-57]. The risk of infection is greater within the first three weeks after tattoo placement [25] because of diminished skin integrity. Delayed-onset development of flat warts associated with human papillomavirus, activation of herpes simplex virus, and infection with Molluscum contagiosum virus have all been documented as complications within the sites of tattoos [57-60].

Although treatment of infected tattoos can be initiated empirically, we obtain bacterial culture of purulent drainage before empiric treatment in case there is failure of treatment [61]. (See "Nontuberculous mycobacterial skin and soft tissue infections in children" and "Cellulitis and skin abscess: Epidemiology, microbiology, clinical manifestations, and diagnosis".)

Outbreaks of community-associated methicillin-resistant S. aureus (CA-MRSA) among tattoo recipients have been associated with lack of adherence to infection control measures in the tattoo studio (eg, changing gloves between clients, hand hygiene, skin antisepsis, disinfection of equipment and surfaces) [54] and recent incarceration of the tattoo artists. (See "Methicillin-resistant Staphylococcus aureus (MRSA) in adults: Epidemiology", section on 'Community-associated MRSA infection'.)

Outbreaks and individual cases of tattoo inoculation with M. chelonae and other nontuberculous mycobacteria species have also been reported [47-49,62-67]. Many of the cases of M. chelonae infection shared several common features: lesions of varying morphology (eg, red papules, pustules, lichenoid papules and plaques) occurring predominantly in areas of gray pigment; onset within 10 days to 5 months of tattoo placement (usually within one to three weeks); and response to appropriate antibiotics (eg, macrolides and quinolones) [47-49,62]. The outbreaks were associated with commercially-obtained prediluted gray ink, and the cases resulted from the use of nonsterile water by the manufacturer or tattoo artist for dilution of black ink to the desired shade of gray [47-49]. The clinical manifestations, diagnosis, and treatment of nontuberculous mycobacterial skin and soft tissue infections are discussed separately. (See "Nontuberculous mycobacterial skin and soft tissue infections in children".)

The US Food and Drug Administration (FDA) encourages health care providers to report tattoo-related adverse events, including infection, to MedWatch: The FDA Safety Information and Adverse Event Reporting Program [46].

Systemic infection — Systemic infections occur less frequently than local infections as a complication of tattoos. Systemic infection is more likely to occur in people who have had amateur tattoos or have not followed the aftercare instructions.

Hepatitis B and C – Hepatitis B and C can be transmitted during tattooing, particularly when tattoos are obtained in unregulated establishments, which may reuse or inadequately sterilize instruments [68-71]. The magnitude of risk is unknown. (See "Epidemiology, transmission, and prevention of hepatitis B virus infection", section on 'Percutaneous inoculation' and "Epidemiology and transmission of hepatitis C virus infection", section on 'Other percutaneous exposures'.)

Human immunodeficiency virus (HIV) infection – Although HIV infection may be transmitted through tattooing, there are no known cases of such transmission [72]. (See "Epidemiology of pediatric HIV infection", section on 'Risk factors for HIV acquisition'.)

Mpox – A few studies have described mpox (previously referred to as monkeypox) infections associated with new tattoos [73,74]. Many of these infections were systemic, but some of the individuals had only a rash at the site of inoculation.

Infective endocarditis Infective endocarditis is an extremely rare complication of tattooing [75-78]. Nonetheless, health care providers should consider the possibility of infective endocarditis in patients who present with unusual clinical events (eg, unexplained fever, rigors, weakness, myalgia, arthralgia, lethargy, or malaise) between one week and two months after tattooing.

The diagnosis and treatment of infective endocarditis are discussed in detail separately. (See "Infective endocarditis in children".)

Sepsis – Recent tattoo placement may provide a portal of entry for systemic bacteremia and sepsis [79-81]. Immunocompromised patients may be at particular risk for infection due to unusual pathogens (eg Vibrio vulnificus following seawater exposure) [79]. We advise patients to avoid recreational water exposure in the weeks after tattoo placement. (See 'Aftercare instructions' above.)

Skin reactions — Skin reactions to permanent or temporary tattoos include acquired hypersensitivity reactions to the tattoo pigment [36,41,82], sarcoidal reactions (picture 4) [83], scleroderma-like reaction [84], granulomatous reactions (picture 5), recurrent inflammation (which may be associated with uveitis) [85], and keloid formation/hypertrophic scarring [86,87]. (See "Cutaneous manifestations of sarcoidosis", section on 'Tattoo sarcoidosis'.)

Permanent tattoos – Delayed hypersensitivity reactions localized to the site of ink injection are well described in association with metallic salts used in tattoo pigments (eg, mercury, chromium, cadmium, cobalt, nickel) [36,41,82].

Dermatitis from a fresh tattoo (non-henna) can initially be treated with a topical glucocorticoid unless it is draining (suggesting superinfection, which requires antimicrobial therapy). Referral to an allergist or dermatologist may be warranted for patients who develop severe local reaction to tattoo pigments or henna or those determined to proceed with tattooing despite a previous local reaction, since these patients may be at increased risk for serious systemic hypersensitivity reaction. (See "Management of allergic contact dermatitis in adults".)

Temporary henna tattoos – Localized hypersensitivity reactions are relatively uncommon after placement of red henna tattoos [88]. Contact allergy to "black henna" tattoos (picture 6) is more common (estimated frequency of 2.5 percent) because of the addition of paraphenylenediamine (PPD), which is highly sensitizing [88]. Localized allergic reactions to PPD are treated in the same way as localized reactions to non-henna tattoos; however, lifelong avoidance of PPD and potentially cross-reacting compounds is recommended. (See "Common allergens in allergic contact dermatitis", section on 'Hair care products' and "Management of allergic contact dermatitis in adults".)

Case reports have also identified localized scarring, persistent hypopigmentation or hyperpigmentation, and anaphylaxis after placement of black henna tattoos or other exposure to black henna (eg, in hair dye) [88].

Cancer — Whether tattoo pigments have local or systemic carcinogenic effects is unclear [38,39]. Some components of tattoo ink have been classified by the International Agency for Research on Cancer as carcinogenic (eg, cadmium and cadmium compounds) or possibly carcinogenic (eg, cobalt sulfate and other soluble cobalt salts, carbon black) to humans [89]. However, extensive reviews of the literature (1938 to 2018) found only 64 cases of skin cancer arising in tattoos (23 cases of squamous cell carcinoma and keratoacanthoma, 30 cases of melanoma, and 11 cases of basal-cell carcinoma) [39,90]. The small number of reported cases suggests a coincidental rather than causal association, but higher quality studies are needed.

Hemolytic crisis in glucose-6-phosphate dehydrogenase deficiency — Red henna may precipitate acute hemolysis in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency. Several cases of fulminant hemolysis have been reported in children with G6PD deficiency after placement of red henna tattoos [88,91,92]. (See "Diagnosis and management of glucose-6-phosphate dehydrogenase (G6PD) deficiency".)

OTHER CONSIDERATIONS — Tattoos may be associated with a variety of other complications or health considerations, including:

Magnetic resonance imaging – Burning sensation and intense pain over tattooed sites that contain heavy deposits of metallic oxides or iron or titanium have been reported [93-97], but the risk appears to be low [98]. In a prospective study that included 585 magnetic resonance imaging sessions (using five different scanners) in 330 volunteers with a total of 932 tattoos, the probability of tattoo-related adverse reaction was estimated to be ≤0.30 percent (95% CI 0.01-1.69 percent) [99]. (See "Anesthesia for magnetic resonance imaging and computed tomography procedures".)

Epidural anesthesia – Whether lumbar tattoos merit special consideration in patients who require lumbar epidural analgesia remains controversial [93,100-104].

Surgery – Tattoos that are located in operative fields (eg, abdominal tattoos) may require special procedures for preservation [105].

Monitoring nevi – Placement of a tattoo near or within a melanocytic nevus can make it difficult to monitor for changes suggestive of melanoma [106,107]. (See "Atypical (dysplastic) nevi", section on 'Full-body skin examination'.)

Pregnancy – Issues related to tattooing in pregnancy are discussed separately. (See "Maternal adaptations to pregnancy: Skin and related structures", section on 'Tattoos and piercing'.)

PREVENTION OF INFECTION — The risk of localized infection can be reduced when the person obtaining the tattoo:

Understands the procedure

Obtains it in an establishment that uses sterile procedures

Follows appropriate aftercare instructions for cleaning and maintenance (see 'The tattooing process' above)

Patients should complete hepatitis B immunization before tattooing. (See "Hepatitis B virus immunization in infants, children, and adolescents".)

To avoid tattoo-related infection, the United States Centers for Disease Control and Prevention and US Food and Drug Administration recommend that tattoo artists [48,108]:

Avoid using products that are not intended for use in tattooing (eg, drawing ink)

Avoid dilution of ink before tattooing; if dilution is necessary, only sterile water should be used

Avoid using nonsterile water (eg, tap water, bottled water, filtered water, distilled water) to wash the skin before or rinse equipment during tattoo placement

Follow aseptic techniques during tattooing (ie, hand hygiene and the use of disposable gloves; using new needles with each tattoo and disposable single-use ink cups)

We do not provide prophylactic antibiotics for patients with congenital heart disease (CHD) before tattooing. The American Heart Association does not recommend prophylactic antibiotics for patients with CHD before obtaining body art (tattoos or body piercings) [109], although some expert clinicians disagree with this recommendation [110-114].

TATTOO REMOVAL — Tattoo removal usually is more involved, takes more time, and is more expensive than tattoo application. Tattoos generally are removed with laser therapy, which usually requires multiple sessions; complete removal is not guaranteed [115]. Techniques that have been used in the past include cryosurgery, thermal cautery, or surgical resection. All of these methods may leave scars or residual pigment. An alternative to removal is covering the unwanted tattoo with another design.

Tattoo removal, including techniques and adverse effects, is discussed separately. (See "Tattoo removal".)

INFORMATION FOR PATIENTS — UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5th to 6th grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10th to 12th grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.

Here are the patient education articles that are relevant to this topic. We encourage you to print or email these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient education" and the keyword[s] of interest.)

Basics topic (see "Patient education: Tattoos and body piercings (The Basics)")

SUMMARY

Tattooing is increasingly common among adolescents and young adults. (See 'Epidemiology' above.)

When counseling patients about tattooing, primary care clinicians can provide education and resources (table 1) to help them make informed decisions. This includes discussion of the motivational factors (ie, perceived benefits) and health risks; choice of the tattoo design, site, and artist; and anticipatory guidance about prevention of infection and when to seek medical care for complications. It also includes a discussion of relative contraindications to tattoo placement. (See 'Counseling patients about tattoos' above.)

Tattooing may be performed by commercial or amateur artists. The tattooing technique and aftercare instructions may affect the risk of complications. (See 'The tattooing process' above.)

Health risks include localized infection, systemic infection, and skin reactions. Whether tattoo pigments have local or systemic carcinogenic effects is unclear. (See 'Health risks' above.)

The risk of infection can be reduced if the patient obtains the procedure in an establishment that uses sterile procedures, follows appropriate aftercare instructions, and completes hepatitis B immunization before tattooing. (See 'Prevention of infection' above.)

Tattoo removal generally is more involved, takes more time, and is more expensive than tattoo application. Complications of tattoo removal include hypopigmentation, hyperpigmentation, hypersensitivity reaction, scarring, and residual pigment. (See "Tattoo removal".)

ACKNOWLEDGMENT — The UpToDate editorial staff acknowledges R Michelle Schmidt, MD, MPH and Myrna L Armstrong, EDd, RN, FAAN, who contributed to an earlier version of this topic review.

  1. Mayers LB, Judelson DA, Moriarty BW, Rundell KW. Prevalence of body art (body piercing and tattooing) in university undergraduates and incidence of medical complications. Mayo Clin Proc 2002; 77:29.
  2. Drews DR, Allison CK, Probst JR. Behavioral and self-concept differences in tattooed and nontattooed college students. Psychol Rep 2000; 86:475.
  3. Forbes GB. College students with tattoos and piercings: motives, family experiences, personality factors, and perception by others. Psychol Rep 2001; 89:774.
  4. Laumann AE, Derick AJ. Tattoos and body piercings in the United States: a national data set. J Am Acad Dermatol 2006; 55:413.
  5. Mayers L, Chiffriller S. Sequential survey of body piercing and tattooing prevalence and medical complication incidence among college students. Arch Pediatr Adolesc Med 2007; 161:1219.
  6. Tattoo takeover: Three in ten Americans have tattoos, and most don't stop at just one www.theharrispoll.com/health-and-life/Tattoo_Takeover.html (Accessed on April 26, 2016).
  7. Armstrong ML, Roberts AE, Owen DC, Koch JR. Toward building a composite of college student influences with body art. Issues Compr Pediatr Nurs 2004; 27:277.
  8. Taylor P, Keeters S. Pew Research Social & Demographic Trends. Millenials: Confident. Connected. Open to Change. Available at: www.pewsocialtrends.org/2010/02/24/millennials-confident-connected-open-to-change/ (Accessed on July 22, 2013).
  9. Braveman S. The Harris Poll (2012). One in Five US Adults Now Has a Tattoo. Available at: www.harrisinteractive.com/NewsRoom/HarrisPolls/tabid/447/mid/1508/articleId/970/ctl/ReadCustom%20Default/Default.aspx (Accessed on August 17, 2013).
  10. King KA, Vidourek RA. Getting inked: Tattoo and risky behavioral involvement among university students. Soc Sci J 2013; 50:540.
  11. Carroll ST, Riffenburgh RH, Roberts TA, Myhre EB. Tattoos and body piercings as indicators of adolescent risk-taking behaviors. Pediatrics 2002; 109:1021.
  12. Roberts TA, Ryan SA. Tattooing and high-risk behavior in adolescents. Pediatrics 2002; 110:1058.
  13. Koch JR, Roberts AE, Armstrong ML, Owen DC. College students, tattoos, and sexual activity. Psychol Rep 2005; 97:887.
  14. Armstrong ML, Owen DC, Roberts AE, Koch JR. College students and tattoos. Influence of image, identity, family, and friends. J Psychosoc Nurs Ment Health Serv 2002; 40:20.
  15. Armstrong ML, Owen DC, Roberts AE, Koch JR. College tattoos: more than skin deep. Dermatol Nurs 2002; 14:317.
  16. Nathanson C, Paulhus DL, Williams KM. Personality and misconduct correlates of body modification and other cultural deviance markers. J Res Pers 2006; 40:779.
  17. Tate JC, Shelton BL. Personality correlates of tattooing and body piercing in a college sample: the kids are alright. Pers Individ Dif 2008; 45:281.
  18. Frederick CM, Bradley KA. A different kind of normal: Psychological and motivational characteristics of young adult tattooers and body piercers. N Am J Psychol 2000; 2:281.
  19. Owen DC, Armstrong ML, Koch JR, Roberts AE. College students with body art: well-being or high-risk behavior? J Psychosoc Nurs Ment Health Serv 2013; 51:20.
  20. Armstrong ML, Tustin J, Owen DC, et al. Body art education: the earlier, the better. J Sch Nurs 2014; 30:12.
  21. Carlson VP, Lehman EJ, Armstrong M. Tattooing regulations in U.S. States, 2011. J Environ Health 2012; 75:30.
  22. Cegolon L, Miatto E, Bortolotto M, et al. Body piercing and tattoo: awareness of health related risks among 4,277 Italian secondary school adolescents. BMC Public Health 2010; 10:73.
  23. Vanston DC, Scott JM. Health risks, medical complications and negative social implications associated with adolescent tattoo and body piercing practices. Vulnerable Child Youth Stud 2008; 3:221.
  24. Armstrong M, McConnell C. Promoting informed decision-making about tattooing for adolescents. J Sch Nurs 1994; 10:27.
  25. Breuner CC, Levine DA, COMMITTEE ON ADOLESCENCE. Adolescent and Young Adult Tattooing, Piercing, and Scarification. Pediatrics 2017; 140.
  26. Roberts AE, Koch JR, Armstrong ML, Owen DC. Correlates of tattoos and reference groups. Psychol Rep 2006; 99:933.
  27. Armstrong ML, Roberts AE, Koch JR, et al. Motivation for contemporary tattoo removal: a shift in identity. Arch Dermatol 2008; 144:879.
  28. Kluger N, De Cuyper C. A Practical Guide About Tattooing in Patients with Chronic Skin Disorders and Other Medical Conditions. Am J Clin Dermatol 2018; 19:167.
  29. Kluger N, Comte C. Isotretinoin and tattooing: a cautionary tale. Int J Dermatol 2017; 56:e199.
  30. Kluger N, Bosonnet S. Keloid occurring in a tattoo. Ann Dermatol Venereol 2017; 144:455.
  31. Kluger N. Tattooing and piercing: an underestimated issue for immunocompromised patients? Presse Med 2013; 42:791.
  32. Armstrong ML. Tattooing, body piercing, and permanent cosmetics: a historical and current view of state regulations, with continuing concerns. J Environ Health 2005; 67:38.
  33. The Alliance of Professional Tattooists Incorporated. www.safe-tattoos.com (Accessed on May 08, 2016).
  34. Armstrong ML, McConnell C. Tattooing in adolescents: more common than you think--the phenomenon and risks. J Sch Nurs 1994; 10:26.
  35. Sperry K. Tattoos and tattooing. Part I: History and methodology. Am J Forensic Med Pathol 1991; 12:313.
  36. Sperry K. Tattoos and tattooing. Part II: Gross pathology, histopathology, medical complications, and applications. Am J Forensic Med Pathol 1992; 13:7.
  37. Baeumler W, Vasold R, Lundsgaard J, Talberg HJ. Chemicals used in tattooing and permanent make up products. In: Workshop on Technical/Scientific and Regulatory Issues on the Safety of Tattoos, Body Piercing and of Related Practices, Papameletiou D, Schwela D, Zenie A (Eds), European commission, Ispra, Italy 2003. p.21.
  38. Laux P, Tralau T, Tentschert J, et al. A medical-toxicological view of tattooing. Lancet 2016; 387:395.
  39. Kluger N, Koljonen V. Tattoos, inks, and cancer. Lancet Oncol 2012; 13:e161.
  40. Beute TC, Miller CH, Timko AL, Ross EV. In vitro spectral analysis of tattoo pigments. Dermatol Surg 2008; 34:508.
  41. Forte G, Petrucci F, Cristaudo A, Bocca B. Market survey on toxic metals contained in tattoo inks. Sci Total Environ 2009; 407:5997.
  42. Timko AL, Miller CH, Johnson FB, Ross E. In vitro quantitative chemical analysis of tattoo pigments. Arch Dermatol 2001; 137:143.
  43. FDA CFSAN/Office of Cosmetics and Colors Tattoos and Permanent Makeup (2006). Available at: www.cfsan.fda.gov/~dms/cos-204.html (Accessed on May 20, 2008).
  44. Engel E, Santarelli F, Vasold R, et al. Modern tattoos cause high concentrations of hazardous pigments in skin. Contact Dermatitis 2008; 58:228.
  45. US Food and Drug Administration.Tattoos and permanent makeup. www.fda.gov/Cosmetics/ProductandIngredientSafety/ProductInformation/ucm108530.htm (Accessed on August 27, 2012).
  46. LeBlanc PM, Hollinger KA, Klontz KC. Tattoo ink-related infections--awareness, diagnosis, reporting, and prevention. N Engl J Med 2012; 367:985.
  47. Drage LA, Ecker PM, Orenstein R, et al. An outbreak of Mycobacterium chelonae infections in tattoos. J Am Acad Dermatol 2010; 62:501.
  48. Centers for Disease Control and Prevention (CDC). Tattoo-associated nontuberculous mycobacterial skin infections--multiple states, 2011-2012. MMWR Morb Mortal Wkly Rep 2012; 61:653.
  49. Kennedy BS, Bedard B, Younge M, et al. Outbreak of Mycobacterium chelonae infection associated with tattoo ink. N Engl J Med 2012; 367:1020.
  50. Kazandjieva J, Grozdev I, Tsankov N. Temporary henna tattoos. Clin Dermatol 2007; 25:383.
  51. Braverman PK. Body art: piercing, tattooing, and scarification. Adolesc Med Clin 2006; 17:505.
  52. Armstrong ML, Kelly L. Tattooing, body piercing, and branding are on the rise: perspectives for school nurses. J Sch Nurs 2001; 17:12.
  53. Long GE, Rickman LS. Infectious complications of tattoos. Clin Infect Dis 1994; 18:610.
  54. Centers for Disease Control and Prevention (CDC). Methicillin-resistant Staphylococcus aureus skin infections among tattoo recipients--Ohio, Kentucky, and Vermont, 2004-2005. MMWR Morb Mortal Wkly Rep 2006; 55:677.
  55. Giulieri S, Morisod B, Edney T, et al. Outbreak of Mycobacterium haemophilum infections after permanent makeup of the eyebrows. Clin Infect Dis 2011; 52:488.
  56. Falsey RR, Kinzer MH, Hurst S, et al. Cutaneous inoculation of nontuberculous mycobacteria during professional tattooing: a case series and epidemiologic study. Clin Infect Dis 2013; 57:e143.
  57. Islam PS, Chang C, Selmi C, et al. Medical Complications of Tattoos: A Comprehensive Review. Clin Rev Allergy Immunol 2016; 50:273.
  58. Kirchhof MG, Wong SM. Tattoos and human papilloma virus: A case report of tattoo-associated flat warts (verrucae planae). SAGE Open Med Case Rep 2019; 7:2050313X19857416.
  59. Brajac I, Loncarek K, Stojnić-Sosa L, Gruber F. Delayed onset of warts over tattoo mark provoked by sunburn. J Eur Acad Dermatol Venereol 2005; 19:247.
  60. Begolli Gerqari A, Ferizi M, Kotori M, et al. Activation of Herpes Simplex Infection after Tattoo. Acta Dermatovenerol Croat 2018; 26:75.
  61. Desai NA, Smith ML. Body art in adolescents: paint, piercings, and perils. Adolesc Med State Art Rev 2011; 22:97.
  62. Kappel S, Cotliar J. Inoculation of Mycobacteria chelonae from a tattoo. J Am Acad Dermatol 2011; 64:998.
  63. Preda VA, Maley M, Sullivan JR. Mycobacterium chelonae infection in a tattoo site. Med J Aust 2009; 190:278.
  64. Kluger N, Muller C, Gral N. Atypical mycobacteria infection following tattooing: review of an outbreak in 8 patients in a French tattoo parlor. Arch Dermatol 2008; 144:941.
  65. Wolf R, Wolf D. A tattooed butterfly as a vector of atypical Mycobacteria. J Am Acad Dermatol 2003; 48:S73.
  66. de Quatrebarbes J, Pestel-Caron M, Duval-Modeste AB, et al. Epidemie a Mycobacterium chelonae chez un tatoueur. Ann Dermatol Venereol 2005; 132(9 Suppl):S224.
  67. Griffin I, Schmitz A, Oliver C, et al. Outbreak of Tattoo-associated Nontuberculous Mycobacterial Skin Infections. Clin Infect Dis 2019; 69:949.
  68. Haley RW, Fischer RP. Commercial tattooing as a potentially important source of hepatitis C infection. Clinical epidemiology of 626 consecutive patients unaware of their hepatitis C serologic status. Medicine (Baltimore) 2001; 80:134.
  69. Tohme RA, Holmberg SD. Transmission of hepatitis C virus infection through tattooing and piercing: a critical review. Clin Infect Dis 2012; 54:1167.
  70. Jafari S, Copes R, Baharlou S, et al. Tattooing and the risk of transmission of hepatitis C: a systematic review and meta-analysis. Int J Infect Dis 2010; 14:e928.
  71. Jafari S, Buxton JA, Afshar K, et al. Tattooing and risk of hepatitis B: a systematic review and meta-analysis. Can J Public Health 2012; 103:207.
  72. Centers for Disease Control and Prevention. HIV transmission. www.cdc.gov/hiv/basics/transmission.html (Accessed on April 20, 2016).
  73. Del Río García V, Palacios JG, Morcillo AM, et al. Monkeypox outbreak in a piercing and tattoo establishment in Spain. Lancet Infect Dis 2022; 22:1526.
  74. Beaumont AL, Raphaël E, Bertin C, et al. Mpox lesions on a tattoo. Lancet Infect Dis 2023; 23:762.
  75. Satchithananda DK, Walsh J, Schofield PM. Bacterial endocarditis following repeated tattooing. Heart 2001; 85:11.
  76. Shebani SO, Miles HF, Simmons P, et al. Awareness of the risk of endocarditis associated with tattooing and body piercing among patients with congenital heart disease and paediatric cardiologists in the United Kingdom. Arch Dis Child 2007; 92:1013.
  77. Armstrong ML, DeBoer S, Cetta F. Infective endocarditis after body art: a review of the literature and concerns. J Adolesc Health 2008; 43:217.
  78. Akkus NI, Mina GS, Fereidoon S, Rajpal S. Tattooing complicated by multivalvular bacterial endocarditis. Herz 2014; 39:349.
  79. Hendren N, Sukumar S, Glazer CS. Vibrio vulnificus septic shock due to a contaminated tattoo. BMJ Case Rep 2017; 2017.
  80. Elegino-Steffens DU, Layman C, Bacomo F, Hsue G. A case of severe septicemia following traditional Samoan tattooing. Hawaii J Med Public Health 2013; 72:5.
  81. Serup J, Carlsen KH, Sepehri M. Tattoo complaints and complications: diagnosis and clinical spectrum. Curr Probl Dermatol 2015; 48:48.
  82. Neri I, Guareschi E, Savoia F, Patrizi A. Childhood allergic contact dermatitis from henna tattoo. Pediatr Dermatol 2002; 19:503.
  83. Kluger N. Sarcoidosis on tattoos: a review of the literature from 1939 to 2011. Sarcoidosis Vasc Diffuse Lung Dis 2013; 30:86.
  84. Kluger N, Mathelier-Fusade P, Moguelet P. Scleroderma-like reaction restricted to the red parts of a tattoo. Acta Derm Venereol 2009; 89:95.
  85. Piggott KD, Rao PK. Blurry Vision and a Black Ink Tattoo. JAMA 2019; 321:699.
  86. Vasilakis V, Knight B, Lidder S, Frankton S. Severe type IV hypersensitivity to 'black henna' tattoo. BMJ Case Rep 2010; 2010.
  87. Lewin PK. Temporary henna tattoo with permanent scarification. CMAJ 1999; 160:310.
  88. de Groot AC. Side-effects of henna and semi-permanent 'black henna' tattoos: a full review. Contact Dermatitis 2013; 69:1.
  89. World Health Organization. International Agency for Research on Cancer. IARC Monographs on the evaluation of carcinogenic risks to humans. http://monographs.iarc.fr/ENG/Classification/index.php (Accessed on May 16, 2012).
  90. Ricci F, Paradisi A, Maier SA, et al. Melanoma and tattoos: a case report and review of the literature. Eur J Dermatol 2018; 28:50.
  91. Raupp P, Hassan JA, Varughese M, Kristiansson B. Henna causes life threatening haemolysis in glucose-6-phosphate dehydrogenase deficiency. Arch Dis Child 2001; 85:411.
  92. Zinkham WH, Oski FA. Henna: a potential cause of oxidative hemolysis and neonatal hyperbilirubinemia. Pediatrics 1996; 97:707.
  93. DeBoer S, Fishman D, Chwals W, et al. Body piercing/tattooing and trauma diagnostic imaging: medical myths vs realities. J Trauma Nurs 2007; 14:35.
  94. Mercier FJ, Bonnet MP. Tattooing and various piercing: anaesthetic considerations. Curr Opin Anaesthesiol 2009; 22:436.
  95. Barclay, L. Anesthetic care for magnetic resonance imaging reviewed. Medscape Medical News. http://cme.medscape.com/viewarticle/589122_print (Accessed on August 17, 2009).
  96. Ross JR, Matava MJ. Tattoo-induced skin "burn" during magnetic resonance imaging in a professional football player: a case report. Sports Health 2011; 3:431.
  97. Wagle WA, Smith M. Tattoo-induced skin burn during MR imaging. AJR Am J Roentgenol 2000; 174:1795.
  98. Alsing KK, Johannesen HH, Hansen RH, Serup J. Tattoo complications and magnetic resonance imaging: a comprehensive review of the literature. Acta Radiol 2020; 61:1695.
  99. Callaghan MF, Negus C, Leff AP, et al. Safety of Tattoos in Persons Undergoing MRI. N Engl J Med 2019; 380:495.
  100. Kuczkowski KM. Lumbar tattoos and lumbar epidural analgesia: unresolved controversies. Can J Anaesth 2008; 55:127.
  101. Ginsburg G. Lumbar tattoos and labour epidurals: bare bones evidence. J Obstet Gynaecol Can 2009; 31:203, 204.
  102. Mavropoulos A, Camann W. Use of a lumbar tattoo to aid spinal anesthesia for cesarean delivery. Int J Obstet Anesth 2009; 18:98.
  103. Kluger N. Body art and pregnancy. Eur J Obstet Gynecol Reprod Biol 2010; 153:3.
  104. Kluger N, Fraitag S, Guillot B, Sleth JC. Why puncturing a lumbar tattoo during epidural analgesia cannot induce an epidermoid tumor. Reg Anesth Pain Med 2010; 35:317.
  105. Smit JM, Scheele K, Lapid O, Hoogbergen MM. Management of tattoos in the operative field. Ann Plast Surg 2010; 64:125.
  106. Kluger N, Thomas L. The dragon with atypical mole syndrome. Arch Dermatol 2008; 144:948.
  107. Tchernev G, Chokoeva AA. Melanoma in a Chinese dragon tattoo. Lancet 2015.
  108. US Food and Drug Administration. Tattoo inks pose health risks. www.fda.gov/ForConsumers/ConsumerUpdates/ucm316357.htm (Accessed on August 27, 2012).
  109. Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007; 116:1736.
  110. Weinberg JB, Blackwood RA. Case report of Staphylococcus aureus endocarditis after navel piercing. Pediatr Infect Dis J 2003; 22:94.
  111. Cetta F, Graham LC, Lichtenberg RC, Warnes CA. Piercing and tattooing in patients with congenital heart disease: patient and physician perspectives. J Adolesc Health 1999; 24:160.
  112. Millar BC, Moore JE. Antibiotic prophylaxis, body piercing and infective endocarditis. J Antimicrob Chemother 2004; 53:123.
  113. Delahaye F, Wong J, Mills PG. Infective endocarditis: a comparison of international guidelines. Heart 2007; 93:524.
  114. Niwa K, Nakazawa M, Miyatake K, et al. Survey of prophylaxis and management of infective endocarditis in patients with congenital heart disease: Japanese nationwide survey. Circ J 2003; 67:585.
  115. Naga LI, Alster TS. Laser Tattoo Removal: An Update. Am J Clin Dermatol 2017; 18:59.
Topic 15721 Version 38.0

References

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟